Lyme Disease Antibody (IgG), Immunoblot
Test Code
29477
86617
Clinical Significance
Lyme Disease Antibody (IgG), Immunoblot - Lyme disease is caused by a tick vector carrying borrelia burgdorferi. Immunoblot testing qualitatively examines with high specificity antibodies in a patient's specimen. Immunoblot testing is appropriate for confirming a detected EIA or IFA test result.
Test Resources
Test FAQ
Lyme Disease TestingClinical Focus
Lyme Disease: Laboratory Support of Diagnosis and ManagementTest Details
Methodology
Immunoblot (IB)
Reference Range(s)
Negative
Alternative Name(s)
Borrelia burgdorferi
Preferred Specimen(s)
1 mL serum
Minimum Volume
0.1 mL
Collection Instructions
Administration of STRENSIQ may interfere in certain assays and may falsely elevate values. For patients receiving STRENSIQ, consideration should be given to using alternate methods.
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 7 days
- Refrigerated: 14 days
- Frozen: 30 days
Reject Criteria
Gross hemolysis • Grossly lipemic
Setup Schedule
1 mL serum
0.1 mL
Administration of STRENSIQ may interfere in certain assays and may falsely elevate values. For patients receiving STRENSIQ, consideration should be given to using alternate methods.
Transport tube
Room temperature
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Gross hemolysis • Grossly lipemic